Verrica Pharmaceuticals Inc. (VRCA) Reports Q2 Loss, Tops Revenue Estimates

Verrica Pharmaceuticals Inc. (VRCA) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of$ 0.43. This compares to loss of $0.21 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 27.91%. A quarter ago, it was expected that this company would post a loss of$ 0.54 per share when it actually produced a loss of $0.38, delivering a surprise of 29.63%. Over the last four quarters, the compa ...